Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
Providor Statement: This continuing medical education activity is provided by
Support Statement: This activity is supported by educational grants from Eisai, Inc.; Takeda Pharmaceuticals International, Inc., U.S. Region and Orexigen; and Vivus, Inc.
Target Audience: The intended audience for this activity is primary care physicians, family physicians, general practice physicians, endocrinologists, cardiologists, obstetrician gynecologists, and other healthcare professionals involved in the management of obese patients.
Learning Objectives: At the conclusion of this series participants should be able to:
Examine the link between the pathophysiology of obesity and associated comorbid conditions.
Select patients for intervention based on evidence-based criteria, which includes diet and lifestyle modifications, pharmacotherapies, and surgery.
Donna H. Ryan, MD, FACP
Pennington Biomedical Research Center
Baton Rouge, LA
Ronald Codario, MD, FACP, FNLA CCMEP (Recertification review on 6/19/14)
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Vindico Medical Education designates this print supplement for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, July 15, 2014 to July 14, 2015.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives and articles, complete the CME posttest, and fill in the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Planning Committee and Faculty members report the following relationship(s) which are accurate at the time of original content release (June 15, 2013):
Donna H. Ryan MD, FACP
Consulting Fees: Arena, Dainippon Sumitomo, Eisai, Novo Nordisk, VIVUS Inc.
Fees for Non-CME Services Received Directly from Commercial Interest or their Agents: VIVUS Inc.
Ownership Interest: Scientific Intake
External Reviewer reports the following relationship(s):
Ronald Codario, MD, FACP, FNLA, CCMEP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
The medical director, Maya Mehta M.D. M.B.A. and production staff of BetterCME have no relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright © 2014 Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions? Contact us at email@example.com.